Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amza Abdou

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Nature Communications|January 29, 2026
Geographic spillover of antimicrobial resistance from mass distribution of azithromycinAriktha Srivathsan, Ahmed M Arzika, Ramatou Maliki, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Geographic spillover of antimicrobial resistance from mass distribution of azithromycinAriktha Srivathsan, Ahmed M Arzika, Ramatou Maliki, et al.
The American Journal of Tropical Medicine and Hygiene|February 25, 2025
Identifying Borderline Trachoma Grades Using a Three-Latent Class ModelVinayak Prathikanti, Renee Casentini, Jonathan Hwang, et al.
The New England Journal of Medicine|November 11, 2020
Macrolide and Nonmacrolide Resistance with Mass Azithromycin DistributionThuy Doan, Lee Worden, Armin Hinterwirth, et al.
JAMA Network Open|December 15, 2023
Distance to Health Centers and Effectiveness of Azithromycin Mass Administration for Children in Niger: A Secondary Analysis of the MORDOR Cluster Randomized TrialDennis L Chao, Ahmed M Arzika, Amza Abdou, et al.
BMJ Global Health|February 10, 2025
Effect of biannual azithromycin on respiratory pathogens among symptomatic children: results from the randomised Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) I trialJie Liu, Stephanie A Brennhofer, Jixian Zhang, et al.
JAMA Network Open|August 18, 2025
Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized TrialAhmed M Arzika, Amza Abdou, Ramatou Maliki, et al.
JAMA Network Open|December 30, 2021
Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized TrialAhmed M Arzika, Ramatou Maliki, Maria M Ali, et al.
BMJ Global Health|October 17, 2022
Simplified dosing of oral azithromycin for children 1-11 months old in child survival programmes: age-based and height-based dosing protocolsHuiyu Hu, Ahmed Mamane Arzika, Ali Sie, et al.
BMJ Global Health|March 28, 2025
Seasonality of underweight among infants 1-11 months old in Niger: an exploratory analysis of data from a cluster-randomised trialBrittany Peterson, Ahmed Mamane Arzika, Ramatou Maliki, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Nature Communications|January 29, 2026
Geographic spillover of antimicrobial resistance from mass distribution of azithromycinAriktha Srivathsan, Ahmed M Arzika, Ramatou Maliki, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Geographic spillover of antimicrobial resistance from mass distribution of azithromycinAriktha Srivathsan, Ahmed M Arzika, Ramatou Maliki, et al.
The American Journal of Tropical Medicine and Hygiene|February 25, 2025
Identifying Borderline Trachoma Grades Using a Three-Latent Class ModelVinayak Prathikanti, Renee Casentini, Jonathan Hwang, et al.
The New England Journal of Medicine|November 11, 2020
Macrolide and Nonmacrolide Resistance with Mass Azithromycin DistributionThuy Doan, Lee Worden, Armin Hinterwirth, et al.
JAMA Network Open|December 15, 2023
Distance to Health Centers and Effectiveness of Azithromycin Mass Administration for Children in Niger: A Secondary Analysis of the MORDOR Cluster Randomized TrialDennis L Chao, Ahmed M Arzika, Amza Abdou, et al.
BMJ Global Health|February 10, 2025
Effect of biannual azithromycin on respiratory pathogens among symptomatic children: results from the randomised Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) I trialJie Liu, Stephanie A Brennhofer, Jixian Zhang, et al.
JAMA Network Open|August 18, 2025
Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized TrialAhmed M Arzika, Amza Abdou, Ramatou Maliki, et al.
JAMA Network Open|December 30, 2021
Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized TrialAhmed M Arzika, Ramatou Maliki, Maria M Ali, et al.
BMJ Global Health|October 17, 2022
Simplified dosing of oral azithromycin for children 1-11 months old in child survival programmes: age-based and height-based dosing protocolsHuiyu Hu, Ahmed Mamane Arzika, Ali Sie, et al.
BMJ Global Health|March 28, 2025
Seasonality of underweight among infants 1-11 months old in Niger: an exploratory analysis of data from a cluster-randomised trialBrittany Peterson, Ahmed Mamane Arzika, Ramatou Maliki, et al.
Pageof 3